Publications

Review articles

Shimano H, Sato R.
SREBP-regulated lipid metabolism: convergent physiology – divergent pathophysiology.
Nat Rev Endocrinol. 13(12):710-730, 2017.

Original articles

Furukawa S, Suzuki H, Fujihara K, Kobayashi K, Iwasaki H, Sugano Y, Yatoh S, Sekiya M, Yahagi N, Shimano H.
Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes.
Diabetes Res Clin Pract. 141:237-243, 2018.

Takeuchi Y, Yahagi N, Aita Y, Murayama Y, Sawada Y, Piao X, Toya N, Oya Y, Shikama A, Takarada A, Masuda Y, Nishi M, Kubota M, Izumida Y, Yamamoto T, Sekiya M, Matsuzaka T, Nakagawa Y, Urayama O, Kawakami Y, Iizuka Y, Gotoda T, Itaka K, Kataoka K, Nagai R, Kadowaki T, Yamada N, Lu Y, Jain MK, Shimano H.
KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting.
Cell Rep. 16(9):2373-86, 2016.

Nakagawa Y, Satoh A, Yabe S, Furusawa M, Tokushige N, Tezuka H, Mikami M, Iwata W, Shingyouchi A, Matsuzaka T, Kiwata S, Fujimoto Y, Shimizu H, Danno H, Yamamoto T, Ishii K, Karasawa T, Takeuchi Y, Iwasaki H, Shimada M, Kawakami Y, Urayama O, Sone H, Takekoshi K, Kobayashi K, Yatoh S, Takahashi A, Yahagi N, Suzuki H, Yamada N, Shimano H.
Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.
Endocrinology. 155(12):4706-19, 2014.

Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N, Iwasaki H, Iwasaki Y, Karasawa T, Kumadaki S, Matsui T, Sekiya M, Ohashi K, Hasty AH, Nakagawa Y, Takahashi A, Suzuki H, Yatoh S, Sone H, Toyoshima H, Osuga J, Yamada N.
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
Nat Med. 13(10):1193-202, 2007.

Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N.
TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
Nat Med. 12(1):107-13, 2006.

Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H.
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
Hepatology. 38(6):1529-39, 2003.

Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL.
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
J Clin Invest. 98(7):1575-84, 1996.

To find our latest papers, please click “PubMed Search.”